Abstract
Infectious and inflammatory diseases are characterized by local generation of inflammatory mediators, and recruitment of inflammatory cells from the circulation into local tissues. These processes are tightly regulated by the cytokines that are produced by lymphocytes and macrophages. Cytokines induce a wide range of secondary mediators, including other cytokines, and interact with various cells in an endocrine, paracrine or autocrine manner. The inflammatory processes that result from infectious and non-infectious stimuli are usually initially related to the severity of the pro-inflammatory stimulus, but at later stages may become dependent on the balance of the production of pro- and anti-inflammatory mediators. Defects in the control of inflammation in part explain the observation that relatively minor injury may cause extensive tissue damage, such as may occur in sepsis and certain autoimmune diseases, and the regulation of cytokine production may be a key factor in the perpetuation of inflammation. The transcription rate of most cytokine genes is strictly regulated, and the production of some cytokines is additionally restricted by translational- and posttranslational control mechanisms. In recent years it has become apparent that cytokine genes are polymorphic, and the presence of certain alleles may correlate with enhanced or reduced cytokine production. Although it has been demonstrated that in some instances such a relationship was directly caused by altered binding of DNA-binding proteins (transcription factors) that regulate transcription, in many cases the precise connection of cytokine gene polymorphisms with the production of specific cytokines on the one hand, and disease severity on the other hand remains uncertain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Refrences
Nedwin GE, Naylor SL, Sakaguchi AY, et al (1985) Human tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucl Acid Res 13: 6361–6373
Nedospasov SA, Shakov AN, Turetskaya RL, et al (1986) Tandem arrangement of the genes coding for human tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in human genome. Cold Spring Harbor Symp Quant Biol 51 : 611–625
Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL (1986) Genes for the tumor necrosis factor-α and β are linked to the human major histocompability complex. Proc Natl Acad Sci USA 83: 8699–8702
Carroll MC, Katzman P, Alicot EM, et al (1987) Linkage map of the human major histocompatibliy complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 84: 8535–8539
Dunham I, Sargent CA, Trowsdale J, Campbell D (1987) Molecular mapping of the human major histocompatibility complex by puIs-field electrophoresis. Proc Natl Acad Sci USA 84: 7237–7241
Partanen J, Koskimies S (1988) Low degree of DNA polymorphisms in the HLA-linked lymphotoxin (tumour necrosis factor β) gene. Scand J Immunol 28: 313–316
Webb GC, Chaplin DD (1990) Genetic variability at the human tumor necrosis factor loci. J Immunol 145: 1278–1285
Fugger L, Morling N, Ryder LP, et al (1989) Ncol restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in primary biliary sclerosis and in healthy Danes. Scand J Immunol 30: 185–189
Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL (1991) DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. J Immunology 147: 1053–1059
Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A (1991) Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 88: 9717–9721
Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turestkaya RL (1993) Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16: 180–186
Messer G, Spengler U, Jung MC, et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 173: 209–219
Pociot F, Mølvig J, Wogensen L, et al (1991) A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33: 37–49
Choo SY, Spies T, Strominger JL, Hansen J (1988) Polymorphism in the tumor necrosis factor gene: Association with HLA-B and DR haplotypes. Hum Immunol 23: 86
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Gale EAM, Botazzo GF (1989) TNF-α gene polymorphisms in type 1 diabetes mellitus. Diabetologia 32: 445–448
Dawkins RL, Leaver A, Cameron PU, Martin E, Kay PH, Christiansen FT (1989) Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol 26: 91–97
Tiwari JI (1985) HLA and disease associations. Springer Verlag, Berlin, pp 32–48
Derkx HHF, Bruin KF, Jongeneel CV, et al (1995) Familial differences in endotoxininduced TNF release in whole blood and peripheral blood mononuclear cells in vitro. Relationship to TNF gene polymorphism. J Endotox Res 2: 19–25
Fugger L, Bendtzen L, Morling N, Ryder L, Svejgaard A (1989) Possible correlation of TNFα-production with RFLP in humans. Eur J Haematol 43: 255–254
Sachs JA, Whichelow CE, Hitman GA, Niven M, Thode H, Meager A (1990) The effect of HLA and insulin-dependent diabetes mellitus on the secretion levels of tumor necrosis factor alpha and beta and gamma interferon. Scand J Immunol 32: 703–708
Pociot F, Briant L, Jongeneel CV (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with secretion of TNF alpha and beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23: 224–231
Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ (1989) Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. J Immunol 143: 913–922
Toungouz M, Denys CH, Andrien ME, De Groote D, Dupont EC (1994) Tumor necrosis factor-α and interleukin-6 production by variations of DR4 polymorphism during the primary mixed lymphocyte reaction. Transplantation 58: 1393–1398
Wilson AG, Di Giovine FS, Blakemore AIF, Duff GW (1992) Single base polymorphism in the human tumor necrosis factor alfa (TNF-α) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1: 353
Wilson AG, De Vries N, Pociot F, di Giovine FS, Van der Putte LBA, Duff GW (1993) An allelic polymorphism within the tumor necrosis factor a promotor is strongly associated with HLA AI, B8, and DR 3 alleles. J Exp Med 177: 557–560
Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW (1994) Effects of tumor necrosis (TNF-a) promotor base transition on transcriptional activity. Br J Rheumatol 33 : 89 (Abst)
Abraham LJ, French MAH, Dawkins RL (1993) Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-α. Clin Exp Immunol 92: 14–18
D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFa promotor region. Immunogenet 39: 150–154
Pociot F, D’ Alfonso S, Compasso S, Scorza R, Richiardi PM (1995) Functional analysis of a new polymorphism in the human TNF-α gene promotor. Scand J Immunol 42: 501–504
Brinkman BMN, Kaijzel EL, Huizinga TWJ, Giphart MJ, Breedveld FC, Verweij CL (1995) Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFα) gene. Hum Genet 96: 493
Webb AC, Collins KL, Auron PE, et al (1986) Interleukin-1 gene (IL-1) assigned to the long arm of human chromosome 2. Lymphokine Res 5: 77–85
Modi WS, Masuda A, Yamada M, et al (1988) Chromosomal localization of the human interleukin-1a gene. Genomics 2: 310–314
Lafage M, Maroc N, Dubreuil P, et al (1989) The human interleukin-1α gene is located on the long arm of chromosome 2 at band q 13. Blood 73: 104–107
Steinkasser A, Spurr NK, Cox S, Jeggo P, Sim RB (1992) The human IL-1 receptor antagonist gene (IL-1ra) maps to chromosome 2q14-q21 in the region of the IL-1α and IL-1β loci. Genomics 13: 654–657
Patterson D, Jones C., Hart I, et al (1993) The human interleukin-1 receptor antagonist (IUra) gene is located in the chromosome 2q14 region. Genomics 15: 173–176
Lennard A, Gorman P, Carrier M, et al (1993) Cloning and chromosome mapping of the interleukin-1 receptor antagonist gene. Cytokine 4: 83–89
Nicklin JH, Weith A, Duff GW (1993) A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin receptor antagonist genes. Genomics 19: 382–384
Furutani Y, Notake M, Fukui T, et al (1986) Complete nucleotide sequence of the gene for human interleukin alpha. Nucleic Acids Res 14: 3167–3179
Bailly S, di Giovine FS, Duff GW (1993) Polymorphic tandem repeat region in interleukin- lα intron 6. Hum Genet 91: 85–86
Bailly S, di Giovine FS, Blakemore AIF, Duff GW (1993) Genetic polymorphism of human interleukin-1α. Eur J Immunol 23: 1240–1245
v/d Velden PA, Reitsma PH (1993) Amino acid dimorphism in IL-1α is detectable by PCR amplification. Hum Mol Genet 2: 1753
Todd S, Naylor SL (1991) Dinucleotide repeat polymorphism in the human interleukin 1 alpha gene (IL-1α) Nucl Acid Res 19: 3756
McDowell TL, Symons JA, Ploski R, Førre Ø, Duff GW (1993) A polymorphism in the region of the interleukin-1 alpha gene is associated with juvenile chronic arthritis. Br J Rheumatol 32 (Suppl 1): 162 (Abst)
di Giovine FS, Takhsh E, Blakemore AIF, Duff GW (1992) Single base polymorphism at-511 in the human interleukin-1β gene (IL-1β). Human Mol Genet 1: 450
Steinkasserer A, Koeble K, Sim RB (1991) Length variation within intron 2 of the human IL-1 receptor antagonist protein gene. Nucleic Acids Res 19: 5095
Tarlow JK, Blakemore AIF, Lennard A, et al (1993) Polymorphism in human receptor antagonist gene intron 2 is caused by variable number of an 86-bp tandem repeat. Hum Genet 91 : 403–404
Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism. Clin Exp Immunol 99: 303–310
McLeod R, Bushman E, Arbuckle LD, Skamene (1995) Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Opin Immunol 7: 539–552
Grau GE, Taylor TE, Molyneux ME (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586–1591
Kwiatkowski D, Hill AV, Sanbou I, et al (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201–1204
Castes M, Trujillo D, Rojas ME, et al (1993) Serum levels of tumor necrosis factor in patients with American cutaneous Leishmaniasis. Biol Res 26: 233–238
Berendt AR, Simmons DL, Transey J, Newbold CI, Marsh K (1989) Intercellular adhesion molecule-l is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341 : 57–59
McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-α promotor region associated with susceptibility to cerebral malaria. Nature 371 : 508–511
Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous Leishmaniasis. J Exp Med 182: 1259–1264
Vincek V, Kurimoto I, Streilein JW (1994) Polymorphism at the tumor necrosis factor-a and susceptibility to toxoplasmic encephalitis, ultraviolet B-induced immune impairment and mouse AIDS. J Acq Imm Def Syn 7: 734–739
Freund YR, Chaim GS, Jacob CO, Suzuki Y, Remington JS (1992) Polymorphisms in the tumor necrosis factor-α (TNF-α) mRNA in infected brain tissue. J Exp Med 175: 683–688
Clay FE, Cork MJ, Tarlow JK, et al (1994) Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerous. Hum Genet 94: 407–410
Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthr Rheum 9: 1380–1385
Cork MJ, Tarlow JK, Clay FE, et al (1995) An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. J Invest Dermatol 104: 15S-16S
Mansfield JC, Holden H, Tadow J, et al (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 antagonist. Gastroenterology 106: 637–642
Isaacs KL, Sartor RB, Haskill S (1992) Cytokine messenger RNA profIles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroentrol 103: 1587–1595
Wilson WG, Duff GW (1995) Genetic traits in common disease support the adage that autoimmunity is the price paid for eradication of infectious disease. Br Med J 310: 1482–1483
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stokkers, P., Camoglio, L., van Deventer, S.J.H. (1996). Cytokine Gene Polymorphisms in Infectious and Inflammatory Diseases. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80053-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-80053-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60552-2
Online ISBN: 978-3-642-80053-5
eBook Packages: Springer Book Archive